Author

M. Nikolski

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Biophysics· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:statistical model· 3 Research Focus:cell type annotation· 2 Approach:deep learning· 2 Research Focus:differential expression· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1

Frequent Co-Authors

A. Bikfalvi· 2 shared M.-A. Derieppe· 2 shared A. Burban· 1 shared A. Emanuelli· 1 shared A. Ravaud· 1 shared A. Sharanek· 1 shared A. Zouine· 1 shared B. Dartigues· 1 shared

Activity by Year

2020-2024 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Bikfalvi

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

Exploiting a metabolic vulnerability in brain tumour stem cells using a brain-penetrant drug with safe profile

A. Burban, C. Tessier, M. Pinglaut, J. Guyon, J. Galvis, B. Dartigues, M. Toujas, M. Larroquette, H. A. Luchman, S. Weiss, N. Nicot, B. Klink, M. Nikolski, L. Brisson, T. Mathivet, , A. Sharanek

This study shows that mubritinib targets brain tumour stem cells by inhibiting complex I of the electron transport chain, delays glioblastoma tumourigenesis, and is safe in mice.

bioRxiv · Jan 15, 2024Cancer Biology

TREM1+ regulatory myeloid cells expand in steatohepatitis-HCC and associate with poor prognosis and therapeutic resistance to immune checkpoint blockade

J. Giraud, D. Chalopin, E. Ramel, T. Boyer, A. Zouine, M.-A. Derieppe, N. Larmonier, O. Adotevi, B. Le Bail, J.-F. Blanc, L. Chiche, M. Nikolski, M. Saleh

This study identifies TREM1+CD163+ regulatory myeloid cells in steatohepatitis-HCC that suppress T cell function and are linked to poor prognosis and resistance to immune checkpoint therapy.

bioRxiv · Nov 9, 2022 · PreprintImmunology

FluoSim: simulator of single molecule dynamics for fluorescence live-cell and super-resolution imaging of membrane proteins

M. Lagardere, I. Chamma, E. Bouilhol, M. Nikolski, O. Thoumine

FluoSim simulates single molecule dynamics for fluorescence live-cell and super-resolution imaging, reconciling imaging paradigms and quantifying protein behavior in cellular environments.

bioRxiv · Feb 6, 2020Biophysics

A multi-layered systems approach for renal cell carcinoma

L. Cooley, J. Rudewicz, W. Souleyreau, K. Clarke, F. Falciani, M. Dufies, S. Verbeke, A. Emanuelli, S. Benzekry, C. Taing, E. J. Ribot, S. Miraux, D. Lambrechts, E. Modave, R. Pineau, , A. Bikfalvi

A multi-layered systems approach identifies prognostic and predictive biomarkers for renal cell carcinoma aggressiveness through in vivo models and integrative analysis.

bioRxiv · Jan 13, 2020 · PreprintCancer Biology